← Leaderboards
Joy Elizabeth Gerasco
Medical University Of South Carolina
$193,210
Attributed
$193,210
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.8K · FY2017–20$100K$75K$50K$25K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$193,210 · 1
By mechanism
F30$193,210 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Hong Yu$1,302,731
- Bethany A. Harbin$155,857
- Chase Mitchell Walton$52,854
Others in their field
Other Emerging Leaders on “Actinobacillus Actinomycetemcomitans”
- Afsar Raza Naqvi · University Of Illinois At Chicago$2,280,126
- Chenggang Wu · University Of Texas Hlth Sci Ctr Houston$1,903,751
- Gina Lewin · Georgia Institute Of Technology$1,052,398
- Shaoping Zhang · University Of Iowa$486,345
- Anuradha Dhingra · University Of Pennsylvania$325,000
- Gaoyan Grace Tang-Siegel · University Of Vermont & St Agric College$312,000
Research focus
Actinobacillus ActinomycetemcomitansAdjuvantAdultActive SitesAffectAmericanAnalogAreaAttenuatedBaseBlindBone LossC57bl/6 MouseCalvariaCharacteristicsComputational ChemistryComputer SoftwareCrispr/Cas TechnologyCrystallizationCytokineCytotoxicityDemethylationDesignDisease Progression
Grant awards (4)
Validation and Development of KDM4B Inhibitors to Target Peridontal Disease$44,990
F30 · FY2020 · DE · contact PI
Validation and Development of KDM4B Inhibitors to Target Peridontal Disease$50,816
F30 · FY2019 · DE · contact PI
Validation and Development of KDM4B Inhibitors to Target Peridontal Disease$50,324
F30 · FY2018 · DE · contact PI
Validation and Development of KDM4B Inhibitors to Target Peridontal Disease$47,080
F30 · FY2017 · DE · contact PI